Liothyronine Sodium Tablets recall: Impurity Out of Spec
Liothyronine Sodium Tablets, USP, 5 mcg Rx ONLY, 100 count bottle, Distributed by: Paddock Laboratories, Inc., Minneapolis, MN 55427, NDC 0574-0220-01,
Why was Liothyronine Sodium Tablets recalled?
Failed Impurities/Degradation Specifications: 3 month stability testing.
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
12K714 exp. 12/13, 12K715 exp. 12/13
- Product
- Liothyronine Sodium Tablets, USP, 5 mcg Rx ONLY, 100 count bottle, Distributed by: Paddock Laboratories, Inc., Minneapolis, MN 55427, NDC 0574-0220-01,
- Recalling firm
- L. Perrigo Co.
- Quantity
- 21,667 bottles
- Distribution
- Nationwide
- Recall date
- May 15, 2013
- Classification
- Class III
- Status
- Terminated
- Agency
- FDA (drug)